CRCP
GHDX

Copper Rock Capital Partners’s Genomic Health, Inc. GHDX Stock Holding History

Copper Rock Capital Partners’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-298,813
Closed -$17.4M – 81
2019
Q2 		$17.4M Sell
298,813
-32,392
-10% -$1.92M 1.29% 49
2019
Q1 		$22.9M Buy
331,205
+38,609
+13% +$2.86M 1.66% 15
2018
Q4 		$18.6M Buy
+292,596
New +$20.5M 1.46% 28

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Copper Rock Capital Partners's GHDX Position: Q3 2019 in Review

Copper Rock Capital Partners sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 298,813 shares — an estimated $17.4M sold.

Copper Rock Capital Partners first reported a position in GHDX in Q4 2018 and held it in 3 quarters. The position peaked at $22.9M in Q1 2019. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Copper Rock Capital Partners reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Copper Rock Capital Partners sold 298,813 Genomic Health, Inc. shares in Q3 2019, an estimated $17.4M.
  • Copper Rock Capital Partners first reported a position in Genomic Health, Inc. in Q4 2018 and held it in 3 quarters.
  • Copper Rock Capital Partners's Genomic Health, Inc. position peaked at $22.9M in Q1 2019.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Copper Rock Capital Partners's 13F filing for Q3 2019, filed 10 Oct 2019.